Yahoo Finanzas Why Hims & Hers Stock Was Down This Week
The stock market certainly had its outperformers as the latest trading week came to a close, but it didn't seem Hims & Hers Health (NYSE: HIMS) would be one of them. As of the pre-market hours on Friday, the specialty healthcare company's shares were trading down by almost 12%, according to data compiled by S&P Global Market Intelligence. That fall can be traced to a new take on the company from a pundit following its trajectory.
A downgrade
Hims & Hers is obeying the law of stock market gravity, which mandates that any company soaring in price must eventually drop, by some level, at some point.
The telehealth specialist was a hot item on the exchange earlier this year, when it released the first set of quarterly results in its history to feature a bottom-line profit. Better, the company beat analyst estimates for both revenue and net income in that (fourth) quarter, and exceeded the average projection for revenue in its full-year guidance.
Some market professionals feel that the resulting share price climb has left the company overvalued. On Tuesday, one of those folks went as far as to downgrade his recommendation on the stock. This was Glen Santangelo of Jefferies, who now feels Hims & Hers is only a hold -- previously he had ranked it a buy. He also cut his price target, albeit slightly, to $15 per share from the former $17.
Solid performance, but richly valued
In his research note detailing the recommendation chop, Santangelo wrote that Hims & Hers has done an admirable job of "executing on many fronts."
"However," Santangelo said, "with expectations now at a more appropriate level (commensurate w share price up roughly 50% year-to-date) and growth slowing, we believe the investment case is better understood."
Should you invest $1,000 in Hims & Hers Health right now?
Before you buy stock in Hims & Hers Health, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $514,887!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
*Stock Advisor returns as of April 15, 2024
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Jefferies Financial Group. The Motley Fool has a disclosure policy.
Why Hims & Hers Stock Was Down This Week was originally published by The Motley Fool
